Abstract：Objective To explore the change of RAGE-NF-κB signaling pathway during the course of hyperoxiainduced lung injury in newborn rats, and the effect of glucocorticoid on this pathway. Methods Twenty-four Sprague- Dawley neonatal rats were randomly divided into three groups (n=8 each): sham control (control group), hyperoxiainduced acute lung injury (model group) and glucocorticoid-treated acute lung injury (glucocorticoid group). Rats were sacrificed at 13 days after birth. RAGE and NF-κB expression levels in lung tissues were detected by reverse transcription polymerase chain reaction, Western blot and immunohistochemistry analysis. The levels of tumor necrosis factor α (TNF-α) and sRAGE in bronchoalveolar lavage fluid (BALF) and serum were measured using ELISA. Lung damage was evaluated by histological examinations. Results RAGE and NF-κB mRNA and protein expression levels in lung tissues were significantly increased in the model and glucocorticoid groups compared with the control group (P<0.05). Serum RAGE concentrations were significantly increased but RAGE concentrations in BALF were significantly reduced in the model and glucocorticoid groups compared with the control group (P<0.05). RAGE and NF-κB expression at both mRNA and protein levels in lung tissues was significantly lower in the glucocorticoid group than in the model group (P<0.05). RAGE concentrations were significantly lower in serum (P<0.05), but were higher in BALF (P<0.05) in the glucocorticoid group than in the model group. Conclusions RAGE-NF-κB pathway plays an important role in hyperoxia-induced lung injury in neonatal rats, and glucocorticoid administration may play a protective role against the lung injury by down-regulating RAGE-NF-κB signaling pathway.
HU Jian,YU Min,TANG Yun et al. Effects of glucocorticoid on RAGE-NF-κB pathway in hyperoxia-induced lung tissues of neonatal rats[J]. CJCP, 2015, 17(1): 81-85.
Guo WA, Knight PR, Raghavendran K. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome[J]. Intensive Care Med, 2012, 38(10): 1588-1598.
[5]
Christie JD, Shah CV, Kawut SM, et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction[J]. Am J Respir Crit Care Med, 2009, 180(10): 1010-1015.
[6]
Tian Z, Li Y, Ji P, et al. Mesenchymal stem cells protects hyperoxia-induced lung injury in newborn rats via inhibiting receptor for advanced glycation end-products/nuclear factor kappaB signaling[J]. Exp Biol Med(Maywood), 2013, 238(2): 242-247.
Matute-Bello G, Winn RK, Jonas M, et al. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation[J]. Am J Pathol, 2001, 158(1): 153-161.
Ambalavanan N, Mourani P. Pulmonary hypertension in bronchopulmonary dysplasia[J]. Birth Defects Res A Clin Mol Teratol, 2014, 100(3): 240-246.
[11]
Yatime L, Andersen GR. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products[J]. FEBS J, 2013, 280(24): 6556-6568.
[12]
Reynolds PR, Wasley KM, Allison CH. Diesel particulate matter induces receptor for advanced glycation end-products(RAGE) expression in pulmonary epithelial cells, and RAGE signaling influences NF-kappaB-mediated inflammation[J]. Environ Health Perspect, 2011, 119(3): 332-336.
Lizotte PP, Hanford LE, Enghild JJ, et al. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung[J]. BMC Dev Biol, 2007, 7: 15.
Su X, Looney MR, Gupta N, et al. Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2009, 297(1): L1-L5.
[18]
Iwamoto H, Gao J, Pulkkinen V, et al. Soluble receptor for advanced glycation end-products and progression of airway disease[J]. BMC Pulm Med, 2014, 14: 68.
